Efficacy and safety of frozen thawed embryo transfer in women aged 35 to 42 years from the PURSUE randomized clinical trial

Tuesday, March 29, 2016

Robert Boostanfar, M.D., Davis Gates, Ph.D., Yanfen Guan, M.S., Keith Gordon, Ph.D., Christine McCrary Sisk, B.S., Barbara J.…

Read More

Large comparative randomized double blind trial confirming noninferiority of pregnancy rates for corifollitropin alfa compared with recombinant follicle stimulating hormone in a gonadotropin releasing hormone antagonist controlled ovarian stimulation protocol in older patients undergoing in vitro fertilization

Monday, June 29, 2015
A single injection of corifollitropin alfa for the first 7 days of controlled ovarian stimulation was as effective as daily recombinant FSH in older IVF patients, and was generally well tolerated.

Read More

Progesterone elevation does not compromise pregnancy rates in high responders a pooled analysis of in vitro fertilization patients treated with recombinant FSH GnRH antagonist in six trials

Wednesday, November 27, 2013
Incidence of elevated P increases with ovarian response, and elevated P (>1.5 ng/mL) is independently associated with a decreased chance of pregnancy in low to normal, but not high, responders.

Read More

Is there a place for corifollitropin alfa in IVF/ICSI cycles? A systematic review and meta-analysis

Thursday, May 10, 2012
We present a meta-analysis evaluating the safety and efficacy of corifollitropin alfa administration in women undergoing controlled ovarian stimulation in GnRH antagonist down-regulated IVF/ICSI treatment cycles.

Read More

Translate »